RFK Jr's latest target is mRNA
Found in 1960s, it was crucial during COVID
By: Scott Fallon
NorthJersey.com
USA Today Network - New Jersey
..... When U.S. Health Secretary Robert F. Kennedy Jr. announced on august 5 [2025 that nearly $500 million to research mRNA vaccines would be canceled, it was one in a continuing line of moves that have put his long-held vaccine skepticism into public policy even though scientists at his own agency say the vaccine are safe.
.....
Kennedy said the termination of funding for 22 mRNA projects would fee up money for "safer broader vaccine platforms that remain effective even as viruses mutate." No new mRNA projects will be initiated, he said. But many scientists say he is effectively canceling research into a promising field that has been shown to be safe and may have multiple health care uses.
..... For more than a century, traditional vaccines have contained weakened or even dead viruses that trigger a person's immune system to develop specific antibodies that resist infection form a specific virus.
..... These traditional vaccines helped wipe out many deadly communicable diseases in the developed world, including polio, hepatitis, measles, smallpox, whooping cough and others that had caused thousands of deaths each year.
..... The term "mRNA: stands for "messenger ribonucleic acid," Vaccines made with this technology also trigger an immune response but without introducing a piece of the virus into a person's body. It uses genetically-engineered molecules that prompt cells to make a protein that corresponds with a protein on a virus. That causes the immune system to produce antibodies against the virus.
..... The discovery of mRNA dates back to the 1960s, and research into vaccine development using it began in the 1990s. By the 2010s, vaccines for viruses ranging from rabies to Ebola were being developed.
.....
It wasn't until the COVID-19 pandemic that the public became aware of mRNA vaccines. Two COVID mRNA vaccines from Moderna and Pfizer were fast-tracked and made available to the public in early 2021.
..... Although the vaccines did not stop transmission, they greatly reduced COVID symptoms. A study by several universities in late July [2025] estimated that vaccinations saved 2.5 million lives worldwide, especially among the elderly.
..... The millions who received COVID mRNA vaccines gave researchers a very large sample size to study its effectiveness and safety, the most extensive monitoring program in U.S. history.
..... There have been some serious said effects linked to the vaccines, including the heart ailments myocarditis and pericarditis in teenage boys and young men. This prompted the federal Food and Drug Administration under Kennedy to require Moderna and Pfizer to list the risks on the label.
.....
But most serious side effects have been rare. Most of those reporting heart disease recovered, and there have been no known deaths or transplants, according to a June [2025] report from the Center for Disease Control and Prevention. there have been no other increased risks, including to pregnant women or their children.
..... Other issues of concern from the public that the vaccines can cause abnormal uterine bleeding and ear ringing, or tinnitus, have not been found.
.....
"It's not to say none of that has happened, but it hasn't been on a widespread scale," said Stephanie Sivera, an infectious disease expert at Montclair State University. [NJ] "We've had almost five years' worth of data to look at, and the mRNA safety record has been pretty clear." The technology used in mRNA vaccines is being researched to see how it can deal with a host of ailments.
..... Among them is a study by Hackensack Meridian Health cancer doctors that has shown promising results using the vaccines to treat late-stage skin cancer. It was not immediately clear whether the funding cuts would have an effect on this project.
..... The Health and Human Services department said on August 5 [2025] that funding for 22 projects would cease, but it identified only a few of them, including Moderna's project to develop an mRNA-based bird flu vaccine.
..... Other entities facing mRNA cuts include Emory University, Pfizer, Luminary Labs and AstraZeneca.